期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

联合用药抗真菌感染的现状与分析 被引量：4

Analysis of Combination Drug Therapy Against Fungal Infections
下载PDF
导出
摘要 临床侵袭性真菌感染越来越受到人们的关注,特别是耐药真菌感染的治疗已成为困扰临床的棘手问题,联合用药抗真菌感染成为研究热点之一。综述抗真菌药物与多种药物联用对不同敏感程度致病菌的抗真菌作用及可能的作用机制的文献资料,为进一步研究新的抗真菌药物及联合用药方案提供思路。 More attention has been paid to the invasive fungal infection, especially to the resistant fungal infec- tions. Drug combination is one of the hot topics in antifungal researches. This article focuses on reviewing the combined antifungal effects and possible mechanisms of different kinds of drugs, which may provide new methods for the further studies.
作者 陈作忠 刘萍 马慧萍
机构地区 淄博市中心医院
出处 《抗感染药学》 2013年第3期166-169,共4页 Anti-infection Pharmacy
关键词 联合用药 抗真菌 协同作用 抗真菌药物 drug combination antifungal drug synergism antifungal agents
分类号 R969.3 [医药卫生—药理学]
  • 相关文献

参考文献23

  • 1张永信.深部真菌感染及抗真菌药的应用[J].上海医药,2004,25(8):341-343. 被引量：17
  • 2李爱民,王睿,刘又宁.难治性真菌感染抗真菌药物联合治疗的研究进展[J].中国药物应用与监测,2008,5(1):52-54. 被引量：9
  • 3Spader TB, Venturini TP, Rossato L, et al. Synergisms of voriconazole or itraconazole combined with other antifun- gal agents against Fusarium spp[J]. Rev Iberoam Micol, 2013,8:S 1130-1406.
  • 4Oz Y, Dag I, Kiraz N. Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei[J]. Mycopathologia,2012, 173(1):27-34.
  • 5Oz Y, Aksit F, Kiraz N.Kiremitci A Short communica- tion: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates[J].Mikrobiyol Bull, 2008,42(1): 149-55.
  • 6Shi W, Chen Z, Chen X, et al. The combination of mino- cycline and fluconazole causes synergistic growth inhibi- tion against Candida albicans: an in vitro interaction of antifungal and antibacterial agents[J].FEMS Yeast Res, 2010,10(7):885-893.
  • 7Marisa HM, Stella M.Bemardo SA. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms[J].Internat JAn- timicrob Agent, 2009,34 : 326-332.
  • 8Venturini TP, Rossato L, Spader TB, et al. In vitro syner- gisms obtained by amphotericin B and voriconazole asso- ciated with non-antifungal agents against Fusarium spp [J].Diagn Microb lnfect Dis, 2011,71 (2): 126-310.
  • 9Del Pozo JL, Frances ML, Hemaez S, et aL Effect of am- photericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms[J].Int J Artif Organs, 2011,34(9):766-770.
  • 10Ku TS, Palanisamy SK, Lee SA. Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vanco- mycin and the interaction between tigecycline and anti- fungals[J].Int J A ntimicrob Agents, 2010,36(5) :441-446.

二级参考文献19

  • 1[16]Meletiadis J.Stergiopoulou T.Petraitiene R.et al.Antagonistic interaction between amphotericin B (AMB) and ravuconazole (RAV) using the bliss independence drug interaction (BIDI) model:in vitro and in vivo correlations[A].In:45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)[C].Washington DC.2005:Abstract #M.
  • 2[17]Kontoyiannis DP.Boktour M.Hanna H.et al.Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis[J].Cancer.2005.103: 2334.
  • 3[18]Marr KA.Boeckh M.Carter RA.et al.Combination antifungal therapy for invasive aspergillosis[J].Clin Infect Dis.2004.39:797.
  • 4[19]Torres HA.Hachem RY.Chemaly RF.Et al.Posaconazole:a broadspectrum triazole antifungal[J].Lancet Infect Dis.2005.5:775.
  • 5[1]Groll AH.Walsh TJ.Uncommon opportunistic fungi:new nosocomial treats[J].Clin Microbiol Infect.2001.7 (Suppl.2):8.
  • 6[2]Mukherjee PK.Sheehan DJ.Hitchcock CA.et al.Combination treatment of invasive fungal infections[J].Clin Microbiol Rev.2005.18:163.
  • 7[3]Louie A.Kaw P.Banerjee P.et al.Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endecarditis and pyelonephritis[J].Antimicrobial Agents and Chemotherapy.2001.45:485.
  • 8[4]Barchiesi F.Schimizzi AM.Najvar LK.et al.Interactions of posaconazole and flucytosine against Cryptococcus neoformans[J].Antimicrobial Agents and Chemotherapy.2001.45:1355.
  • 9[5]Gomez-Lopez A.Cuenca-Estrella M.Mellado E.et al.ln vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota[J].Diagnostic Microbiology and Infectious Diseases.2003.45:199.
  • 10[6]Manavathu EK.Alangaden CJ.Chandrasekar PH.Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus[J]Journal of Antimicrobial Chemotherapy.2003.51:1423.

共引文献24

同被引文献22

引证文献4

二级引证文献25

抗感染药学
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部